Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Balen V currently holds 68,263 shares of Cardlytics, Inc. (CDLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Balen V has been a net seller of CDLX stock. They have purchased $996.2K and sold $29.7M worth of shares.
John Balen V's most recent insider trade was on May 24, 2023, when they sold 6,465 shares at $0.00 per share.
John Balen V serves as Executive at Cardlytics, Inc. (CDLX). They have executed 44 insider transactions totaling $30.7M over their tenure at the company.
John Balen V holds the position of Executive at Cardlytics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
John Balen V has shown a selling trading pattern, with $996.2K in total purchases and $29.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Balen V was on May 31, 2011, when they sold $20.6M worth of ACTV shares. This transaction involved 1,371,701 shares at $15.00 per share.
John Balen V currently owns 68,263 shares of Cardlytics, Inc. (CDLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Balen V's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Balen V has 44 Form 4 filings on record as an insider at Cardlytics, Inc..
Set alerts for John Balen V and 40,000+ other insiders.